Renu Regunathan-Shenk* and Jai Radhakrishnan* Pages 140 - 144 ( 5 )
Systemic Lupus Erythematosis (SLE) is a heterogeneous and complex disease produced by diverse pathogenic events in the innate and adaptive immune system. Lupus nephritis affects over half of all patients with lupus and leads to substantial morbidity and mortality. This review presents our current understanding of the development of lupus nephritis and examines the role of genetics and epigenetics in further elucidating the pathogenesis of the disease. Advancements in genomics are leading the way to better understanding and novel biologic therapies for SLE.
Systemic lupus erythematosus, lupus nephritis, precision medicine, personalized medicine, genetics, ANA.
Columbia College of Physicians & Surgeons - Medicine-Nephrology, New York, NY, Columbia College of Physicians & Surgeons - Medicine-Nephrology, New York, NY